Why the study?
Does a dual chamber pacemaker with a rate drop response algorithm prevent syncope in a patient with malignant vasovagal syncope?
Population
1 29-year-old man with malignant vasovagal syncope presenting with >10 episodes of abrupt loss of…
Design
Case_report
Authors
Loading...
May support pacing in refractory malignant vasovagal syncope; leaves open confirmation in randomized trials.
Does a dual chamber pacemaker with a rate drop response algorithm prevent syncope in a patient with malignant vasovagal syncope?
A dual chamber pacemaker with a rate drop response algorithm may be an effective therapy for preventing syncope in patients with malignant vasovagal syncope refractory to medical therapy.
Abe et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: